Hepatic Medicine: Evidence and Research
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.5 | Q3 | 45.1% | — | — | |
| 2024 | 1.8 | Q3 | 34.0% | — | — | |
| 2023 | 2.6 | Q2 | 57.3% | — | — | |
| 2022 | 2.1 | 39.3% | — | — | ||
| 2021 | — | 37.3% | — | — | ||
| 2019 | — | — | 0.598 | Q3 | 72.5% | |
| 2018 | — | — | 0.124 | Q4 | 11.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1179-1535
country
NZ